Showing results (41-50 of 96) with videos related to
Sort By:
Pageof 10
Circulation|September 6, 2001
Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) StudyA R Sharrett, C M Ballantyne, S A Coady, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1994
Murine VCAM-1. Molecular cloning, mapping, and analysis of a truncated formA G Kumar, X Y Dai, C A Kozak, et al.International Journal of Clinical Practice|August 18, 2004
Long-term safety and tolerability profile of ezetimibe and atorvastatin coadministration therapy in patients with primary hypercholesterolaemiaC M Ballantyne, L J Lipka, P T Sager, et al.Current Opinion in Lipidology|December 31, 1997
Effects of lipid lowering therapy on progression of coronary and carotid artery diseaseC M Ballantyne, J A Herd, J K Dunn, et al.Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|July 27, 2007
Glutamic acid decarboxylase antibodies are indicators of the course, but not of the onset, of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities StudyA Vigo, B B Duncan, M I Schmidt, et al.Circulation|April 1, 1996
Levels of soluble cell adhesion molecules in patients with dyslipidemiaA Hackman, Y Abe, W Insull, et al.Controlled Clinical Trials|December 1, 1996
The Lipoprotein and Coronary Atherosclerosis Study (LCAS): design, methods, and baseline data of a trial of fluvastatin in patients without severe hypercholesterolemiaM S West, J A Herd, C M Ballantyne, et al.JAMA|July 7, 1989
Effects of cyclosporine therapy on plasma lipoprotein levelsC M Ballantyne, E J Podet, W P Patsch, et al.American Journal of Physiology. Heart and Circulatory Physiology|April 6, 2000
A chronic mouse model of myocardial ischemia-reperfusion: essential in cytokine studiesT O Nossuli, V Lakshminarayanan, G Baumgarten, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 24, 1999
Endothelial alpha 2,6-linked sialic acid inhibits VCAM-1-dependent adhesion under flow conditionsY Abe, C W Smith, J P Katkin, et al.Pageof 10